Daejeon, South Korea

Hunsoo Park


 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hunsoo Park

Introduction

Hunsoo Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods for producing pyrrole compounds. With a total of 4 patents to his name, Park's work is recognized for its potential applications in the pharmaceutical industry.

Latest Patents

Hunsoo Park's latest patents focus on the production methods of pyrrole compounds. One of his inventions provides a method for producing a 3-cyanopyrrole compound, which is potentially useful as an intermediate for pharmaceutical products. This method includes a reduction reaction where compound (I) is subjected to a continuous hydrogenation reaction in a fixed bed reactor filled with a supported metal catalyst. Additionally, he has developed a production method for compound (III), which involves a reduction reaction followed by a cyclization reaction, also utilizing the continuous hydrogenation process.

Career Highlights

Hunsoo Park is currently associated with Takeda Pharmaceutical Company Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work has been instrumental in advancing methods that could lead to more efficient production processes in drug development.

Collaborations

Throughout his career, Hunsoo Park has collaborated with notable colleagues, including Takashi Ouchi and Giho Goh. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Hunsoo Park's innovative work in the production of pyrrole compounds showcases his dedication to advancing pharmaceutical science. His contributions are expected to have a lasting impact on the industry, paving the way for new therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…